Gen Digital Inc. — Form 10-Q Summary
Business and reporting period: Gen provides consumer cybersecurity, identity protection, privacy and related services under brands including Norton, Avast, LifeLock, Avira and AVG. The report covers fiscal third-quarter 2024, the 13 weeks ended December 29, 2023, and the first nine months of fiscal 2024. Comparisons are with the corresponding periods a year earlier. Gen reports as one segment.
Financial performance
| Metric | Quarter ended Dec. 29, 2023 | Quarter ended Dec. 30, 2022 | Nine months ended Dec. 29, 2023 | Nine months ended Dec. 30, 2022 |
|---|---|---|---|---|
| Revenue | $951 million | $936 million | $2.845 billion | $2.391 billion |
| Gross profit / margin | $769 million / 81% | $758 million / 81% | $2.304 billion / 81% | $1.992 billion / 83% |
| Operating income / margin | $335 million / 35% | $368 million / 39% | $722 million / 25% | $870 million / 36% |
| Net income / margin | $144 million / 15% | $165 million / 18% | $482 million / 17% | $434 million / 18% |
| Diluted earnings per share | $0.22 | $0.25 | $0.75 | $0.70 |
| Operating cash flow | Not separately provided for the quarter | $666 million | $433 million |
Revenue mix: Quarterly consumer security revenue was $602 million, up from $590 million; identity and information protection revenue was $334 million, up from $323 million; legacy revenue declined to $15 million from $23 million. For the nine-month comparison, Gen attributed $419 million of revenue growth to an additional five and a half months of Avast contribution, as Avast was acquired in September 2022. Quarterly direct customer count was 38.9 million versus 38.4 million, direct ARPU was $7.21 versus $7.09, and retention was 77% versus 75%.
Liquidity, debt and balance sheet
- Cash and cash equivalents were $490 million at December 29, 2023, down from $750 million at March 31, 2023. The filing reports an $899 million tax refund received on January 26, 2024, recorded as a receivable in the quarter-end balance sheet.
- Outstanding debt principal was $9.375 billion; debt carrying value was $9.256 billion. Cash was therefore substantially below total debt. Gen had no borrowings on its $1.5 billion revolving credit facility and reported compliance with debt covenants.
- Variable-rate debt was $6.768 billion. Gen estimated that a 100-basis-point SOFR change would alter annualized interest expense by about $68 million. Swaps effectively fixed rates on $1 billion of Term A borrowings through March 2026.
- Nine-month investing cash flow was positive $4 million, compared with negative $6.546 billion in the prior period, principally because the prior period included the Avast acquisition. Financing cash flow was negative $930 million; Gen repaid $525 million of debt, paid $245 million in dividends and repurchased $141 million of shares.
- Contract liabilities were $1.744 billion, down from $1.788 billion at March 31, 2023. Remaining performance obligations were $1.147 billion, excluding $597 million of customer deposit liabilities; Gen expected to recognize about 93% of those obligations as revenue in the next 12 months.
Changes, outlook and notable matters
- Quarterly revenue increased 2%, while operating income fell 9% and net income fell 13%. Management attributed the operating-income decrease primarily to a GSA litigation accrual, partly offset by lower restructuring costs, higher revenue and post-acquisition cost synergies. Higher interest expense also weighed on earnings.
- Nine-month revenue rose 19%, substantially reflecting the added Avast contribution. Operating income declined 17%, reflecting legal accruals and higher acquired-intangible amortization. Net income increased 11%, primarily because of a tax benefit, despite lower operating income and higher interest expense.
- The nine-month tax provision included a $285 million net benefit from an internal legal-entity and operational restructuring. The effective tax rate was negative 98%; management said the final tax outcome could differ and materially affect future results.
- Gen accrued approximately $580 million as the low end of its estimated probable loss for the Columbia University patent case, which is under appeal. The company said additional loss is reasonably possible but cannot be reasonably estimated.
- For the GSA matter, a January 16, 2024 court amendment awarded $53 million in damages and penalties; Gen accrued that amount and is assessing appeal options. Additional loss is reasonably possible but not estimable.
- Gen expects total costs of up to $150 million under its Avast-related restructuring plan, with actions expected to be completed by the end of fiscal 2024. It had incurred $104 million through December 29, 2023.
- Management said existing cash, operating cash generation and revolver availability should be sufficient for working capital, ongoing activities and expected synergy costs for at least the next 12 months. The filing provides no quantified revenue or earnings guidance. A $0.125-per-share dividend for payment in March 2024 was announced after quarter-end; future dividends remain subject to board approval.
- Risks highlighted include substantial indebtedness and floating-rate exposure, litigation and regulatory matters, customer retention and competition, cybersecurity and privacy obligations, foreign-exchange movements, inflation, and geopolitical and other macroeconomic conditions. Management reported effective disclosure controls and no material change in internal control over financial reporting during the quarter.
Important facts for investors to verify
- Track developments in the Columbia appeal and the GSA judgment, including potential payments beyond recorded accruals.
- Assess the durability of earnings excluding the $285 million tax benefit, and monitor the $899 million tax refund and related tax positions.
- Review debt repayment capacity, refinancing needs, interest-rate sensitivity and covenant headroom; the filing does not state a net leverage ratio.
- Separate organic growth from the acquisition-related comparison effect, and monitor customer count, ARPU and retention trends.
- Monitor Avast integration savings and restructuring costs, as well as unresolved privacy-related proceedings, including the FTC matter.